1. Zhang X, Sun J, Yu W, Jin J (2021) Current views on the genetic landscape and management of variant acute promyelocytic leukemia. Biomark Res 9:33. https://doi.org/10.1186/s40364-021-00284-x
2. Rabade N, Raval G, Chaudhary S, Subramanian PG, Kodgule R, Joshi S et al (2018) Molecular heterogeneity in acute promyelocytic leukemia-a single center experience from India. Mediterr J Hematol Infect Dis 10:e2018002
3. Sobas M, Talarn-Forcadell MC, Martínez-Cuadrón D, Escoda L, García-Pérez MJ, Mariz J et al (2020) PLZF-RARα, NPM1-RARα, and other acute promyelocytic leukemia variants: the PETHEMA registry experience and systematic literature review. Cancers 12:E1313
4. Grimwade D, Biondi A, Mozziconacci MJ, Hagemeijer A, Berger R, Neat M, et al (2000) Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European working party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d’hematologie cellulaire, UK cancer cytogenetics group and BIOMED 1 European community-concerted action. “Molecular cytogenetic diagnosis in haematological malignancies”. Blood 96:1297–308
5. Sainty D, Liso V, Cantù-Rajnoldi A, Head D, Mozziconacci MJ, Arnoulet C et al (2000) A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements. Blood 96:1287–1296